Matthew Brams
Fondatore presso CINGULATE INC.
Patrimonio netto: 27 310 $ in data 30/04/2024
Posizioni attive di Matthew Brams
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CINGULATE INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2013 | - |
| Fondatore | 01/01/2013 | - | |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2014 | - | |
| Fondatore | - | - | |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Direttore Tecnico/Scientifico/R&S | 01/01/2013 | - |
| Fondatore | 01/01/2013 | - | |
| Baylor College of Medicine | Corporate Officer/Principal | - | - |
Storia della carriera di Matthew Brams
Precedenti posizioni note di Matthew Brams
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Bayou City Research, Inc. | Direttore Tecnico/Scientifico/R&S | 01/04/1999 | 01/01/2021 |
Formazione di Matthew Brams
| The University of Texas at Austin | Undergraduate Degree |
| University of Texas Health Science Center at Houston | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
| Director/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Bayou City Research, Inc. |
- Borsa valori
- Insiders
- Matthew Brams
- Esperienza
